DrugPatentWatch Database Preview

CROMOLYN SODIUM Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Cromolyn Sodium patents expire, and what generic alternatives are available?

Cromolyn Sodium is a drug marketed by Ailex Pharms Llc, Genera Pharms, Micro Labs Ltd India, Rising Pharms Inc, Akorn, Apotex Inc, Sandoz Inc, Actavis Mid Atlantic, Bausch And Lomb, Fera Pharms Llc, Mylan Speciality Lp, Roxane, Teva Pharms, Watson Labs, Wockhardt Bio Ag, Hh And P, and Perrigo. and is included in twenty-one NDAs.

The generic ingredient in CROMOLYN SODIUM is cromolyn sodium. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.

Summary for CROMOLYN SODIUM

US Patents:	0
Applicants:	17
NDAs:	21
Suppliers / Packagers:	12
Bulk Api Vendors:	66
Clinical Trials:	2,434
Patent Applications:	4,164
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CROMOLYN SODIUM
DailyMed Link:	CROMOLYN SODIUM at DailyMed

Pharmacology for CROMOLYN SODIUM

Drug Class	Mast Cell Stabilizer
Physiological Effect	Decreased Histamine Release

Medical Subject Heading (MeSH) Categories for CROMOLYN SODIUM

Anti-Asthmatic Agents

Synonyms for CROMOLYN SODIUM

1,3-Bis(2-carboxychromon-5-yloxy)-2-hydroxypropane

1,3-Di(2-carboxy-4-oxochromen-5-yloxy)propan-2-ol

105878-73-7

15826-37-6

16110-51-3 (Cromolyn)

16636-EP2281563A1

16636-EP2314298A1

16636-EP2316459A1

4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-, disodium salt

4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxy-1,3-propanediyl)bis(oxy))bis(4-oxo-, disodium salt)

4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxytrimethylene)dioxy)bis(4-oxo-, disodium salt

4H-1-Benzopyran-2-carboxylic acid, 5,5'-((2-hydroxytrimethylene)dioxy)bis(4-oxo-,disodium salt

4H-1-Benzopyran-2-carboxylic acid, 5,5'-[(2-hydroxy-1,3-propanediyl) bis(oxy)]bis[4-oxo-, disodium salt

5-[3-(2-carboxy-4-oxochromen-5-yloxy)-2-hydroxypropoxy]-4-oxochromene-2-carbox ylic acid, sodium salt, sodium salt

5,5'-((2-Hydroxytrimethylene)dioxy)bis(4-oxo-4H-1-benzopyran-2-carboxylic acid) disodium salt

5,5'-(2-Hydroxytrimethylenedioxy)bis(4-oxochromene-2-carboxylic acid)

5,5'-[(2-Hydroxy-1,3-propanediyl)bis(oxy)]bis(4-oxo-4H-1-benzopyran-2-carboxylic Acid) Disodium Salt

87016-01-1

93356-84-4

Aarane

Aararre

AB0013247

AB2000369

AC-18734

AC1L1DCY

ACMC-20eni6

AK163517

AKOS015895760

AKOS015913923

AKOS016339565

AN-8075

API0002134

B3300

Bicromat Spray

C23H14Na2O11

C23H14O11.2Na

CAS-15826-37-6

CCG-40261

CCRIS 3194

CHEBI:128458

CHEMBL74

Chromolyn sodium

Crolom

Cromo asma aerosol

Cromoglicinsaeure, dinatriumsalz

Cromoglycate disodium

Cromolyn (sodium)

Cromolyn disodium salt

Cromolyn sodium (USP)

Cromolyn sodium [USAN:USP]

Cromolyn sodium [USAN]

Cromolyn sodium salt

Cromolynsodium

Cromoptic

CS-2361

CTK8F0841

D00526

D01IGI

Dinatrium cromoglicicum

Dinatrium salz von 1,3-bis-(2-carboxychromon-5-yloxy)-2-hydroxypropan

Dinatrium salz von 1,3-bis-(2-carboxychromon-5-yloxy)-2-hydroxypropan [German]

dipotassium cromoglycate(2-)

disodium 5-[3-(2-carboxylato-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylate

disodium 5-[3-(2-carboxylato-4-oxo-chromen-5-yl)oxy-2-hydroxy-propoxy]-4-oxo-chromene-2-carboxylate

disodium 5-[3-(2-carboxylato-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylate

disodium 5-{3-[(2-carboxylato-4-oxo-4H-chromen-5-yl)oxy]-2-hydroxypropoxy}-4-oxo-4H-chromene-2-carboxylate

Disodium 5,5'-((2-hydroxytrimethylene)bis(oxy))bis(4-oxo-4H-1-benzopyran-2-carboxylate)

Disodium 5,5'-((2-hydroxytrimethylene)dioxy)bis(4-oxo-4H-1-benzopyran-2-carboxylate)

disodium 5,5'-[(2-hydroxypropane-1,3-diyl)bis(oxy)]bis(4-oxo-4H-chromene-2-carboxylate)

Disodium 5,5'-[(2-hydroxytrimethylene)dioxy]bis[4-oxo-4H-1-benzopyran-2-carboxylate]

Disodium cromoglycate

disodium cromoglycate(2-)

disodium;5-[3-(2-carboxylato-4-oxochromen-5-yl)oxy-2-hydroxypropoxy]-4-oxochromene-2-carboxylate

DR003109

DSCG

DSSTox_CID_24554

DSSTox_GSID_44554

DSSTox_RID_80311

DTXSID7044554

EINECS 239-926-7

Epitope ID:122681

FPL 670

FPL-670

FPL.670

Frenasma

FT-0082168

FT-0602030

Gastrocrom

Gastrocrom (TN)

Gastrofrenal

GP8420

Gynazole

H769

HE315110

HE315111

HMS1570D05

HMS1920A18

HMS2089N09

HMS2091I06

HMS2097D05

HMS502K19

HY-B0320A

I06-1500

I14-45144

Inostral (Anti-asthmatic)

Intal

Intal nebulizer

J-009487

J10281

K-4967

KS-00000FYJ

KS-5299

KSC950Q4D

Lomuda

Lomudal

Lomudas

Lomusol

LS-39176

MCULE-8432777058

MFCD00057744

MolPort-002-509-361

Nalcrom

Nasalcrom

Nasmil

Natrii cromoglicas

Natrium cromoglicat

Natrium cromoglicat [German]

NCGC00017083-01

NCGC00017083-02

NCGC00017083-03

NCGC00021142-02

NCGC00022858-08

NCGC00094633-01

NCGC00094633-02

NCGC00255950-01

Nebulasma

NSC 109500

Opticrom

Prestwick_996

Q2WXR1I0PK

RTR-006665

Rynacrom

s1911

SCHEMBL7500

Sodium Chromoglycate

sodium cromoglicate

Sodium cromoglicate (JP17)

Sodium cromoglicate [JAN]

Sodium cromoglycate

Sodium cromolyn

Sodium Cromoylycate

Sodium salt of 5-[3-(2-carboxy-4-oxo-4H-5-chromenyloxy)-2-hydroxypropoxy]-4-oxo-4H-2-chromenecarboxylic acid

SPECTRUM1500210

ST50999688

STOCK1N-03646

Tox21_110863

Tox21_110863_1

Tox21_302003

UNII-Q2WXR1I0PK

Vicrom

US Patents and Regulatory Information for CROMOLYN SODIUM

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ailex Pharms Llc	CROMOLYN SODIUM	cromolyn sodium	CONCENTRATE;ORAL	209264-001	Oct 16, 2017	AA	RX	No	No
Actavis Mid Atlantic	CROMOLYN SODIUM	cromolyn sodium	SPRAY, METERED;NASAL	074800-001	Jul 26, 2001		DISCN	No	No
Sandoz Inc	CROMOLYN SODIUM	cromolyn sodium	SOLUTION/DROPS;OPHTHALMIC	075282-001	Jun 16, 1999	AT	RX	No	No
Rising Pharms Inc	CROMOLYN SODIUM	cromolyn sodium	CONCENTRATE;ORAL	202583-001	Oct 27, 2011	AA	RX	No	No

  Purchase this report

or, see our see our flat-rate plans

  Purchase this report

or, see our see our flat-rate plans